Purepac/Teva Generic Gabapentin Approval Stayed By Court
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer’s Neurontin will not face generic competition from the “first filer” on gabapentin capsules until 2005 at the earliest. The stay, however, does not impact approvals Ivax currently holds on gabapentin tablets.